Drug intelligence / Profile preview

SNG100

Development stage
Phase 1
Lead developer
Seanergy Dermatology
Modality
Small Molecules
Administration
Topical
01

Overview

**SNG100** is an investigational topical cream developed by Seanergy Dermatology for moderate atopic dermatitis. It is a proprietary formulation of **hydrocortisone 1%** in an SNG vehicle containing sulphated polysaccharides derived from the red microalga *Porphyridium cruentum*. Hydrocortisone is a low-potency topical corticosteroid that acts primarily through the glucocorticoid receptor to suppress cutaneous inflammation and pruritus; the sulphated-polysaccharide vehicle is intended to provide hydrating, moisturizing, lubricating, and skin-barrier-supporting properties. In a randomized Phase I active-controlled study in patients aged 6 years or older with moderate atopic dermatitis, SNG100 showed favorable tolerability and exploratory efficacy relative to hydrocortisone 1% cream and mometasone furoate 0.1% cream.

Other names
SNG100 creamSNG-100 creamSNG 100 cream
02

Targets

PDE6 (Phosphodiesterase 6)

Beyond the preview

Go deeper on SNG100.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNG100.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call